| Pharmaceutical supply chain risks: a systematic review M Jaberidoost, S Nikfar, A Abdollahiasl, R Dinarvand DARU Journal of Pharmaceutical Sciences 21, 1-7, 2013 | 156 | 2013 |
| Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries A Kebriaeezadeh, NN Koopaei, A Abdollahiasl, S Nikfar, N Mohamadi DARU journal of pharmaceutical Sciences 21, 1-8, 2013 | 79 | 2013 |
| Patterns of antibiotic consumption in Iran during 2000-2009. A Abdollahiasl, A Kebriaeezadeh, S Nikfar, A Farshchi, G Ghiasi, ... International journal of antimicrobial agents, 2011 | 47 | 2011 |
| Cost and utilization study of antidotes: an Iranian experience. S Nikfar, M Khatibi, A Abdollahi-Asl, M Abdollahi | 44 | 2011 |
| A system dynamics model for national drug policy A Abdollahiasl, A Kebriaeezadeh, R Dinarvand, M Abdollahi, ... Daru journal of pharmaceutical sciences 22, 1-13, 2014 | 28 | 2014 |
| The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review A Nabizadeh, B Amani, M Kadivar, M Toroski, AA Asl, Y Bayazidi, ... Journal of Research in Pharmacy Practice 7 (4), 171-177, 2018 | 14 | 2018 |
| Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions A Abdollahias, S Nikfar, M Abdollahi Med. Sci 7, 365-367, 2011 | 14 | 2011 |
| A model for developing a decision support system to simulate national drug policy indicators A Abdollahiasl, S Nikfar, A Kebriaeezadeh, R Dinarvand, M Abdollahi | 14 | |
| An overview to pharmaceutical financing in Iran M Varmaghani, A Hashemi-Meshkini, A Abdollahiasl, E Heidari, HS Zekri, ... Journal of Pharmacoeconomics and Pharmaceutical Management 2 (1/2), 45-49, 2016 | 12 | 2016 |
| Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies MA Rezvanfar, A Kebriaeezadeh, M Moein, S Nikfar, Z Gharibnaseri, ... Journal of research in pharmacy practice 2 (4), 162-168, 2013 | 12 | 2013 |
| Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation … M Mensa Sorato, M Davari, A Abdollahi Asl, F Soleymani, ... Journal of Pharmaceutical Health Services Research 11 (4), 321-333, 2020 | 11 | 2020 |
| Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis A Olyaaeemanesh, E Jaafaripooyan, A Abdollahiasl, M Davari, ... Health Research Policy and Systems 19, 1-17, 2021 | 9 | 2021 |
| Availability, pricing and affordability of selected medicines for noncommunicable diseases E Heidari, M Varmaghani, A Abdollahiasl Eastern Mediterranean Health Journal 25 (7), 473-480, 2019 | 9 | 2019 |
| Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children Z Gharibnaseri, A Kebriaeezadeh, S Nikfar, G Zamani, A Abdollahiasl DARU Journal of Pharmaceutical Sciences 20, 1-6, 2012 | 9 | 2012 |
| PHP41 Risk management in iranian pharmaceutical companies to ensure accessibility and quality of medicines M Jaberidoost, A Abdollahiasl, A Farshchi, R Dinarvand Value in Health 15 (7), A616-A617, 2012 | 9 | 2012 |
| Efficacies of regulatory policies to control massive use of diphenoxylate A Farshchi, M Jaberidoost, A Abdollahiasl, M Abdollahi INTERNATIONAL JOURNAL OF PHARMACOLOGY 8 (5), 459-462, 2012 | 7 | 2012 |
| Healthcare resource utilization and cost of care for Gaucher patients in Iran M Davari, A Nabizadeh, M Kadivar, A Abdollahiasl, P Sarkheil Journal of Diabetes & Metabolic Disorders 18 (1), 127-132, 2019 | 6 | 2019 |
| A new approach in identifying and evaluating quality risks in the pharmaceutical industry M Hajimolaali, A Kebriaeezadeh, A Abdollahiasl, H Safari, A Yektadoost Journal of Pharmacoeconomics and Pharmaceutical Management 3 (1/2), 17-20, 2017 | 5 | 2017 |
| PHP13 Affordability of antibacterial medicines in Iran during 2001-2010 A Abdollahiasl, M Jaberidoost, A Farshchi Value in Health 15 (7), A611, 2012 | 5 | 2012 |
| PHP25 market analysis of antibiotics consumption in northern part of Iran during 2001-2010 P Zaboli, S Ala, AK Zadeh, A Abdollahiasl, S Nikfar Value in Health 15 (7), A613-A614, 2012 | 5 | 2012 |
Shekoufeh NikfarProfessor of Pharmacoeconomics, Tehran University of Medical Sciences (TUMS), IranVerified email at tums.ac.ir
